Publications in High Impact Factor Journals

Publications in Journals with an Impact Factor of 10.0 or Greater
 

1. Hiding in plain sight.
   Fayanju OLM.
   JAMA. 2019 Dec 10;322(22):2173-2174.
    
2. Antigen-loaded monocyte administration induces potent therapeutic antitumor T cell responses.
   Huang MN, Nicholson LT, Batich KA, Swartz AM, Kopin D, Wellford S, Prabhakar VK, Woroniecka K, Nair SK, Fecci PE, Sampson JH, Gunn MD.
   J Clin Invest. 2020 Feb 3;130(2):774-788.
    
3. In vivo delivery of synthetic DNA-encoded antibodies induces broad HIV-1-neutralizing activity.
   Wise MC, Xu Z, Tello-Ruiz E, Beck C, Trautz A, Patel A, Elliott ST, Chokkalingam N, Kim S, Kerkau MG, Muthumani K, Jiang J, Fisher PD, Ramos SJ, Smith TR, Mendoza J, Broderick KE, Montefiori DC, Ferrari G, Kulp DW, Humeau LM, Weiner DB.
   J Clin Invest. 2020 Feb 3;130(2):827-837.
    

4. Assessing quality of surgical real-world data from an automated electronic health record pipeline.
   Corey KM, Helmkamp J, Simons M, Curtis L, Marsolo K, Balu S, Gao M, Nichols M, Watson J, Mureebe L, Kirk AD, Sendak M.
   J Am Coll Surg. 2020 Mar;230(3):295-305.e12.
    

5. Intravital imaging of mouse embryos.
   Huang Q, Cohen MA, Alsina FC, Devlin G, Garrett A, McKey J, Havlik P, Rakhilin N, Wang E, Xiang K, Mathews P, Wang L, Bock C, Ruthig V, Wang Y, Negrete M, Wong CW, Murthy PKL, Zhang S, Daniel AR, Kirsch DG, Kang Y, Capel B, Asokan A, Silver DL, Jaenisch R, Shen X.
   Science. 2020 Apr 10;368(6487):181-186.
    

6. Assessing the utility of post-mastectomy imaging after breast reconstruction.
   Shammas RL, Broadwater G, Cason RW, Glener AD, Sergesketter AR, Vernon R, Le E, Wickenheisser VA, Marks C, Hollenbeck ST.
   J Am Coll Surg. 2020 Apr;230(4):605-614.e1.
    

7. Curing HIV: seeking to target and clear persistent infection.
   Margolis DM, Archin NM, Cohen MS, Eron JJ, Ferrari G, Garcia JV, Gay CL, Goonetilleke N, Joseph SB, Swanstrom R, Turner AW, Wahl A.
   Cell. 2020 Apr 2;181(1):189-206.
    

8. The Human Tumor Atlas Network: charting tumor transitions across space and time at single-cell resolution.
   Rozenblatt-Rosen O, Regev A, Oberdoerffer P, Nawy T, Hupalowska A, Rood JE, Ashenberg O, Cerami E, Coffey RJ, Demir E, Ding L, Esplin ED, Ford JM, Goecks J, Ghosh S, Gray JW, Guinney J, Hanlon SE, Hughes SK, Hwang ES, Iacobuzio-Donahue CA, Jané-Valbuena J, Johnson BE, Lau KS, Lively T, Mazzilli SA, Pe'er D, Santagata S, Shalek AK, Schapiro D, Snyder MP, Sorger PK, Spira AE, Srivastava S, Tan K, West RB, Williams EH; Human Tumor Atlas Network.
   Cell. 2020 Apr 16;181(2):236-249.
    

9. T cell-inducing vaccine durably prevents mucosal SHIV infection even with lower neutralizing antibody titers.
   Arunachalam PS, Charles TP, Joag V, Bollimpelli VS, Scott MKD, Wimmers F, Burton SL, Labranche CC, Petitdemange C, Gangadhara S, Styles TM, Quarnstrom CF, Walter KA, Ketas TJ, Legere T, Jagadeesh Reddy PB, Kasturi SP, Tsai A, Yeung BZ, Gupta S, Tomai M, Vasilakos J, Shaw GM, Kang CY, Moore JP, Subramaniam S, Khatri P, Montefiori D, Kozlowski PA, Derdeyn CA, Hunter E, Masopust D, Amara RR, Pulendran B.
   Nat Med. 2020 Jun;26(6):932-940.
    

10. Reframing surgical risk using geriatric assessment measures.
    McDonald SR, Barbeito A, Lagoo-Deenadayalan SA.
    JAMA Surg. 2020 May 1;155(5):418-419.
     

11. Gangliosides are essential endosomal receptors for quasi-enveloped and naked hepatitis A virus.
    Das A, Barrientos R, Shiota T, Madigan V, Misumi I, McKnight KL, Sun L, Li Z, Meganck RM, Li Y, Kaluzna E, Asokan A, Whitmire JK, Kapustina M, Zhang Q, Lemon SM.
    Nat Microbiol. 2020 Sep;5(9):1069-1078.
     

12. Association of clinical outcomes with left ventricular assist device use by bridge to transplant or destination therapy intent: the Multicenter Study of MagLev Technology in Patients Undergoing Mechanical Circulatory Support Therapy With HeartMate 3 (MOMENTUM 3) randomized clinical trial.
    Goldstein DJ, Naka Y, Horstmanshof D, Ravichandran AK, Schroder J, Ransom J, Itoh A, Uriel N, Cleveland JC Jr, Raval NY, Cogswell R, Suarez EE, Lowes BD, Kim G, Bonde P, Sheikh FH, Sood P, Farrar DJ, Mehra MR.
    JAMA Cardiol. 2020 Apr 1;5(4):411-419.
     

13. RGEN editing of RNA and DNA: the long and winding road from catalytic RNAs to CRISPR to the clinic.
    Sullenger BA.
    Cell. 2020 May 28;181(5):955-960.
     

14. Glycopeptide epitope facilitates HIV-1 envelope specific humoral immune responses by eliciting T cell help.
    Sun L, Paschall AV, Middleton DR, Ishihara M, Ozdilek A, Wantuch PL, Aceil J, Duke JA, LaBranche CC, Tiemeyer M, Avci FY.
    Nat Commun. 2020 May 21;11(1):2550.
     

15. Transplant center variability in organ offer acceptance and mortality among US patients on the heart transplant waitlist.
    Choi AY, Mulvihill MS, Lee HJ, Zhao C, Kuchibhatla M, Schroder JN, Patel CB, Granger CB, Hartwig MG.
    JAMA Cardiol. 2020 Jun 1;5(6):660-668. 
     

16. 3M-052, a synthetic TLR-7/8 agonist, induces durable HIV-1 envelope-specific plasma cells and humoral immunity in nonhuman primates.
    Kasturi SP, Rasheed MAU, Havenar-Daughton C, Pham M, Legere T, Sher ZJ, Kovalenkov Y, Gumber S, Huang JY, Gottardo R, Fulp W, Sato A, Sawant S, Stanfield-Oakley S, Yates N, LaBranche C, Alam SM, Tomaras G, Ferrari G, Montefiori D, Wrammert J, Villinger F, Tomai M, Vasilakos J, Fox CB, Reed SG, Haynes BF, Crotty S, Ahmed R, Pulendran B.
    Sci Immunol. 2020 Jun 19;5(48):eabb1025. 
     

17. Regulatory cell therapy in kidney transplantation (The ONE Study): a harmonised design and analysis of seven non-randomised, single-arm, phase 1/2A trials.
    Sawitzki B, Harden PN, Reinke P, Moreau A, Hutchinson JA, Game DS, Tang Q, Guinan EC, Battaglia M, Burlingham WJ, Roberts ISD, Streitz M, Josien R, Böger CA, Scottà C, Markmann JF, Hester JL, Juerchott K, Braudeau C, James B, Contreras-Ruiz L, van der Net JB, Bergler T, Caldara R, Petchey W, Edinger M, Dupas N, Kapinsky M, Mutzbauer I, Otto NM, Öllinger R, Hernandez-Fuentes MP, Issa F, Ahrens N, Meyenberg C, Karitzky S, Kunzendorf U, Knechtle SJ, Grinyó J, Morris PJ, Brent L, Bushell A, Turka LA, Bluestone JA, Lechler RI, Schlitt HJ, Cuturi MC, Schlickeiser S, Friend PJ, Miloud T, Scheffold A, Secchi A, Crisalli K, Kang SM, Hilton R, Banas B, Blancho G, Volk HD, Lombardi G, Wood KJ, Geissler EK.
    Lancet. 2020 May 23;395(10237):1627-1639.
     

18. Non-neuronal expression of SARS-CoV-2 entry genes in the olfactory system suggests mechanisms underlying COVID-19-associated anosmia.
    Brann DH, Tsukahara T, Weinreb C, Lipovsek M, Van den Berge K, Gong B, Chance R, Macaulay IC, Chou HJ, Fletcher RB, Das D, Street K, de Bezieux HR, Choi YG, Risso D, Dudoit S, Purdom E, Mill J, Hachem RA, Matsunami H, Logan DW, Goldstein BJ, Grubb MS, Ngai J, Datta SR.
    Sci Adv. 2020 Jul 31;6(31):eabc5801.
     

19. Controlling the SARS-CoV-2 spike glycoprotein conformation.
    Henderson R, Edwards RJ, Mansouri K, Janowska K, Stalls V, Gobeil SMC, Kopp M, Li D, Parks R, Hsu AL, Borgnia MJ, Haynes BF, Acharya P.
    Nat Struct Mol Biol. 2020 Jul 22.
     

20. Immune checkpoint modulation enhances HIV-1 antibody induction.
    Bradley T, Kuraoka M, Yeh CH, Tian M, Chen H, Cain DW, Chen X, Cheng C, Ellebedy AH, Parks R, Barr M, Sutherland LL, Scearce RM, Bowman CM, Bouton-Verville H, Santra S, Wiehe K, Lewis MG, Ogbe A, Borrow P, Montefiori D, Bonsignori M, Anthony Moody M, Verkoczy L, Saunders KO, Ahmed R, Mascola JR, Kelsoe G, Alt FW, Haynes BF.
    Nat Commun. 2020 Feb 19;11(1):948.
     

21. Safety and immune responses after a 12-month booster in healthy HIV-uninfected adults in HVTN 100 in South Africa: A randomized double-blind placebo-controlled trial of ALVAC-HIV (vCP2438) and bivalent subtype C gp120/MF59 vaccines.
    Laher F, Moodie Z, Cohen KW, Grunenberg N, Bekker LG, Allen M, Frahm N, Yates NL, Morris L, Malahleha M, Mngadi K, Daniels B, Innes C, Saunders K, Grant S, Yu C, Gilbert PB, Phogat S, DiazGranados CA, Koutsoukos M, Van Der Meeren O, Bentley C, Mkhize NN, Pensiero MN, Mehra VL, Kublin JG, Corey L, Montefiori DC, Gray GE, McElrath MJ, Tomaras GD.
    PLoS Med. 2020 Feb 24;17(2):e1003038.
     

22. Minimal barriers to invasion during human colorectal tumor growth.
    Ryser MD, Mallo D, Hall A, Hardman T, King LM, Tatishchev S, Sorribes IC, Maley CC, Marks JR, Hwang ES, Shibata D.
    Nat Commun. 2020 Mar 9;11(1):1280.